Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/1999
03/10/1999EP0900845A2 Signal recognition particle polypeptides and polynucleotides
03/10/1999EP0900844A2 Membrane protein of Staphylococcus aureus
03/10/1999EP0900843A2 FfH polypeptide from Streptococcus
03/10/1999EP0900235A1 Fragments of cr1 and their use
03/10/1999EP0900225A1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
03/10/1999EP0900202A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
03/10/1999EP0900201A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
03/10/1999EP0900083A1 Novel substituted imidazole compounds
03/10/1999EP0900080A1 Novel indole and benzothiazole derivatives
03/10/1999CN1210465A Method of treatment and pharmaceutical composition
03/10/1999CN1210464A Aqueous formulation comprising bambuterol and use thereof
03/10/1999CN1210014A External-use ointment for chronic bronchitis and pulmonary emphysema
03/09/1999US5880104 Administering a plasmid vector encoding a fusion protein lacking a transmembrane region
03/09/1999CA2243656A1 Response regulator
03/04/1999WO1999010313A1 N-aroylphenylalanine derivatives
03/04/1999WO1999010312A1 N-alkanoylphenylalanine derivatives
03/04/1999WO1999009998A1 Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases
03/04/1999WO1999009983A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
03/04/1999WO1999009957A1 Pharmaceutical composition for combination of piperidinoalkanol-decongestant
03/04/1999WO1999009955A2 Lipid-containing compositions and uses thereof
03/04/1999WO1998055606A3 Lactoferrin receptor genes of moraxella
03/04/1999WO1998055074A3 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
03/04/1999CA2301549A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
03/04/1999CA2300146A1 Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases
03/04/1999CA2300121A1 N-alkanoylphenylalanine derivatives
03/04/1999CA2245755A1 2-(arylphenyl)amino-imidazoline derivatives
03/04/1999CA2242258A1 Novel compounds
03/03/1999EP0899338A2 Seryl tRNA synthetase of Streptococcus pneumoniae (serS)
03/03/1999EP0899336A2 Streptococcus pneumoniae spoIIIE protein
03/03/1999EP0899334A2 FtsZ polypeptides from Streptococcus pneumoniae
03/03/1999EP0899333A2 Ribonucleotide reductase gene nrdD from Staphylococcus aureus
03/03/1999EP0899332A2 The G-protein coupled receptor HFIAO41
03/03/1999EP0899329A2 DextranaseB gene from Streptococcus pneumoniae
03/03/1999EP0899261A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists
03/03/1999EP0626957B1 Styril derivatives and processes for their preparation
03/03/1999CN1042329C Substituted cyclohexane derivative for curing diseases
03/03/1999CA2242313A1 Signal recognition particle polypeptides and polynucleotides
03/02/1999US5877342 Skin disorders; respiratory system disorders; cardiovascular disorders
03/02/1999US5877321 Neurokinin receptor
03/02/1999US5877190 Substituted biphenyl compounds
03/02/1999US5877179 Cystic fibrosis
03/02/1999US5877016 Human trk receptors and neurotrophic factor inhibitors
03/02/1999CA2242315A1 Mecb
03/02/1999CA2242252A1 Dexb
03/02/1999CA2241417A1 Novel ffh
02/1999
02/28/1999CA2241427A1 Novel pyrr homolog
02/28/1999CA2241400A1 Ftsy
02/26/1999CA2241431A1 Novel spoiiie
02/25/1999WO1999009186A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
02/25/1999WO1999009162A2 Delayed progression to aids by a missense allele of the ccr2 gene
02/25/1999WO1999009147A1 Truncated platelet-activating factor acetylhydrolase
02/25/1999WO1999009054A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
02/25/1999WO1999008690A1 Method of enhancing bioavailability of fexofenadine and its derivatives
02/25/1999WO1998053050A3 Short peptides which selectively modulate the activity of serine/threonine kinases
02/25/1999DE19837386A1 New CCR-3 antagonist piperazine derivatives and analogues
02/25/1999CA2301374A1 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
02/25/1999CA2300093A1 Delayed progression to aids by a missense allele of the ccr2 gene
02/25/1999CA2298866A1 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
02/25/1999CA2241403A1 Murb
02/24/1999EP0897986A2 Aspartic proteinase 5 (ASP5)
02/24/1999EP0897980A2 CXCR4B: A human splice variant of CXCR4 chemokine receptor
02/24/1999EP0897979A2 Human sdr2 cdna clone
02/24/1999EP0897913A1 4-carboxamido piperidine derivatives and their use as neurokinine antagonists
02/24/1999EP0449968B1 Process for the preparation of human dnase
02/24/1999CN1208617A Nose drops
02/24/1999CN1042228C Antiallergic imidazoazepines
02/23/1999US5874585 Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
02/23/1999US5874566 Il-15 triplex oligonucleotides
02/23/1999US5874420 Process for regulating vagal tone
02/23/1999US5874406 Synthetic peptide analogs of lung surface protein SP-C
02/23/1999US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences
02/23/1999US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor
02/23/1999US5874224 Growth factor receptor binding protein
02/23/1999US5874080 Administering a therapeutic polypeptide antiallergens to inhabit elastase release by neutrophils
02/23/1999US5873359 Methods and devices for treating pulmonary vasoconstriction and asthma
02/23/1999CA2176255C Isoxazoline compounds as antiinflammatory agents
02/23/1999CA2146007C Substituted quinuclidines
02/21/1999CA2241428A1 Asp5
02/20/1999CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor
02/18/1999WO1999007729A2 Peptides having potassium channel opener activity
02/18/1999WO1999007703A1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
02/18/1999WO1999007681A1 2-acylaminopropanamines as tachykinin receptor antagonists
02/18/1999WO1999007670A1 Anthranilic acid analogs
02/18/1999WO1999007669A1 Anthranilic acid analogs
02/18/1999WO1999007405A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF αvβ6
02/18/1999WO1999007396A1 Composition comprising propolis and at least an essential oil
02/18/1999WO1999007351A2 Indole derivatives and their use as mcp-1 antagonists
02/18/1999CA2301669A1 Peptides having potassium channel opener activity
02/18/1999CA2301068A1 Composition comprising propolis and at least an essential oil
02/18/1999CA2298702A1 2-acylaminopropanamines as tachykinin receptor antagonists
02/18/1999CA2297736A1 Treatment of acute lung injury and fibrosis with antagonists of .alpha.v.beta.6
02/18/1999CA2297412A1 Anthranilic acid analogs
02/18/1999CA2297409A1 Anthranilic acid analogs
02/18/1999CA2297290A1 Chemical compounds
02/18/1999CA2245043A1 Ccr-3 receptor antagonists
02/18/1999CA2245041A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists
02/17/1999EP0897011A2 Novel arginine deiminase
02/17/1999EP0897008A2 His5
02/17/1999EP0897004A2 Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS)
02/17/1999EP0896822A1 4-Aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
1 ... 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 ... 878